Qiagen (QGEN) EBITDA (2009 - 2025)

Qiagen has reported EBITDA for 17 years, with the latest figure at $616.0 million in Q4 2025.

• Quarterly EBITDA rose 8.64% year-over-year to $616.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 billion (up 11.84% YoY) and the FY2025 annual result came in at $616.0 million, up 8.64% from the prior year.
• EBITDA grew to $616.0 million in Q4 2025 per QGEN's latest filing, from $129.2 million in the prior quarter.
• Over five years, EBITDA peaked at $755.0 million in Q4 2021 and troughed at $96.7 million in Q1 2023.
• A 5-year average of $240.6 million and a median of $144.0 million in 2025 frame the typical range for EBITDA.
• The sharpest annual moves came in 2021 and 2022: EBITDA surged 384.24% in 2021, then slumped 82.12% in 2022.
• Over 5 years, EBITDA stood at $755.0 million in 2021, then plunged by 82.12% to $135.0 million in 2022, then jumped by 291.85% to $529.0 million in 2023, then gained by 7.18% to $567.0 million in 2024, then rose by 8.64% to $616.0 million in 2025.
• According to Business Quant data, EBITDA over the past three periods registered $616.0 million, $129.2 million, and $160.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.